Phase
Registration
Welcome to the Resources page for the $101M XPRIZE Healthspan and $10M FSHD Bonus Prize. We are currently in the Primary Registration and Qualifying Submissions phase of the Competition. Please see below resources that provide important information for all teams interested in competing to review. We will be updating the contents of this page with more resources as they become available.
Additional questions not covered in these resource documents should be queried to healthspan@xprize.org.
*Signatures required via Docusign; Competing teams must access the POP competition portal to sign the Agreement.
For competing Teams, please refer to the following resources for information on how to enter a Qualifying Submission for XPRIZE Healthspan and the FSHD Bonus Prize.
DEADLINE: Teams have until December 20, 2024 to complete all registration activities and submit their Qualifying Submissions for eligibility of a Milestone 1 Award in 2025. Teams who are interested in competing in both Healthspan and FSHD Bonus Prize must submit two applications.
IMPORTANT: All Qualifying Submissions from Teams must be submitted through the XPRIZE Prize Operations Platform (www.pop.xprize.org). We will not accept any submissions through any other form of transmission.
XPRIZE competitions are driven by teams of innovative groups and individuals, comprising subject matter experts, enthusiasts, start-ups, student teams, amateurs, and all problem-solvers in between. A winning idea can come from anyone, anywhere.
Note: The competition is void in those countries where prohibited or restricted by U.S. law. XPRIZE reserves the right to limit, or restrict upon notice, participation in the competition to any person or entity at any time for any reason. Teams may withdraw from the competition as set forth in the Competitor Agreement.
If you have questions about how to create a Team Profile on POP and how to complete all required activities and submissions, please review the “How-To Guide: Register A XPRIZE Healthspan Team on POP” linked above.